BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11779161)

  • 1. Prostaglandin E(2) stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6/GP130/STAT-3 signaling pathway.
    Liu XH; Kirschenbaum A; Lu M; Yao S; Klausner A; Preston C; Holland JF; Levine AC
    Biochem Biophys Res Commun; 2002 Jan; 290(1):249-55. PubMed ID: 11779161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of gp130-mediated tyrosine phosphorylation of STAT3 and its DNA-binding activity in dexamethasone-treated AIDS-associated Kaposi's sarcoma cells: selective synergy between dexamethasone and gp130-related growth factors in Kaposi's sarcoma cell proliferation.
    Murakami-Mori K; Mori S; Taga T; Kishimoto T; Nakamura S
    J Immunol; 1997 Jun; 158(11):5518-26. PubMed ID: 9164976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors.
    Hirano T; Ishihara K; Hibi M
    Oncogene; 2000 May; 19(21):2548-56. PubMed ID: 10851053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells.
    Dahéron L; Opitz SL; Zaehres H; Lensch MW; Andrews PW; Itskovitz-Eldor J; Daley GQ
    Stem Cells; 2004; 22(5):770-8. PubMed ID: 15342941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo.
    Atreya R; Mudter J; Finotto S; Müllberg J; Jostock T; Wirtz S; Schütz M; Bartsch B; Holtmann M; Becker C; Strand D; Czaja J; Schlaak JF; Lehr HA; Autschbach F; Schürmann G; Nishimoto N; Yoshizaki K; Ito H; Kishimoto T; Galle PR; Rose-John S; Neurath MF
    Nat Med; 2000 May; 6(5):583-8. PubMed ID: 10802717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No inhibition of IL-27 signaling by soluble gp130.
    Scheller J; Schuster B; Hölscher C; Yoshimoto T; Rose-John S
    Biochem Biophys Res Commun; 2005 Jan; 326(4):724-8. PubMed ID: 15607729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT3 is dispensable for maintenance of self-renewal in nonhuman primate embryonic stem cells.
    Sumi T; Fujimoto Y; Nakatsuji N; Suemori H
    Stem Cells; 2004; 22(5):861-72. PubMed ID: 15342949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signal transducer and activator of transcription STAT3 plays a major role in gp130-mediated acute phase protein gene activation.
    May P; Schniertshauer U; Gerhartz C; Horn F; Heinrich PC
    Acta Biochim Pol; 2003; 50(3):595-601. PubMed ID: 14515142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF; Wang Y; Cho JY; Libermann TA
    Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.
    Song L; Turkson J; Karras JG; Jove R; Haura EB
    Oncogene; 2003 Jul; 22(27):4150-65. PubMed ID: 12833138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma.
    Campbell CL; Jiang Z; Savarese DM; Savarese TM
    Am J Pathol; 2001 Jan; 158(1):25-32. PubMed ID: 11141475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway.
    Wei LH; Kuo ML; Chen CA; Chou CH; Lai KB; Lee CN; Hsieh CY
    Oncogene; 2003 Mar; 22(10):1517-27. PubMed ID: 12629515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 inhibits cell proliferation in a rat model of hepatocellular carcinoma.
    Moran DM; Mayes N; Koniaris LG; Cahill PA; McKillop IH
    Liver Int; 2005 Apr; 25(2):445-57. PubMed ID: 15780071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6/soluble interleukin-6 receptor signaling attenuates proliferation and invasion, and induces morphological changes of a newly established pleomorphic malignant fibrous histiocytoma cell line.
    Nakanishi H; Yoshioka K; Joyama S; Araki N; Myoui A; Ishiguro S; Ueda T; Yoshikawa H; Itoh K
    Am J Pathol; 2004 Aug; 165(2):471-80. PubMed ID: 15277221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression and effects of gp130 cytokines and receptors in prostate cancer cells.
    Palmer J; Hertzog PJ; Hammacher A
    Int J Biochem Cell Biol; 2004 Nov; 36(11):2258-69. PubMed ID: 15313471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer.
    Dalwadi H; Krysan K; Heuze-Vourc'h N; Dohadwala M; Elashoff D; Sharma S; Cacalano N; Lichtenstein A; Dubinett S
    Clin Cancer Res; 2005 Nov; 11(21):7674-82. PubMed ID: 16278387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy.
    Selander KS; Li L; Watson L; Merrell M; Dahmen H; Heinrich PC; Müller-Newen G; Harris KW
    Cancer Res; 2004 Oct; 64(19):6924-33. PubMed ID: 15466183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of gp130 and STAT3 activation in the rat hippocampus following transient forebrain ischemia.
    Choi JS; Kim SY; Cha JH; Choi YS; Sung KW; Oh ST; Kim ON; Chung JW; Chun MH; Lee SB; Lee MY
    Glia; 2003 Feb; 41(3):237-46. PubMed ID: 12528179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
    Narayanan BA; Narayanan NK; Pittman B; Reddy BS
    Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins.
    Blanchard F; Kinzie E; Wang Y; Duplomb L; Godard A; Held WA; Asch BB; Baumann H
    Oncogene; 2002 Sep; 21(41):6264-77. PubMed ID: 12214267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.